Impact of Clinical Pharmacists Intervention on Management of Hyperglycemia In pregnancy in Jordan

Overview

Journal Int J Clin Pharm

Publisher Springer

Specialties Pharmacology
Pharmacy

Date 2017 Nov 15

PMID 29134488

Citations 6

Authors

Razan Adnan Batta

Violet Kasabri

Amal Akour

Dana Hyassat

Abla Albsoul-Younes

Affiliations

Soon will be listed here.

Abstract

Background and objective Hyperglycemia in pregnancy is a risk factor for cardiovascular disease and postpartum (PP) diabetes. This study aimed to assess the impact of the clinical pharmacist-assisted program (CPAP) of optimizing drug therapy and intensive education on main management outcome measures of patient knowledge about diabetes, Quality of life (QoL) as measured by SF-36 including maternal complications, fasting plasma glucose (FPG) control, and HbA1c. Method This is a randomized controlled study. Pregnant (20-28 weeks) patients with hyperglycemia received CPAP (n = 51) as compared with conventional management (n = 34). Patients were then followed up for 6 weeks pp. Results A significant change was shown in the intervention group for diabetes knowledge (3.47% vs. control 2.03%, P < 0.05) and three aspects of health-related QoL. The need for caesarian delivery (58.8% vs. control 35.3%) and severe episodes of hypoglycemia (0% vs. control 8.8%) were significantly (P < 0.05) reduced in the intervention group. Six weeks PP reduction in HbA1c values was greater in the intervention group (- 0.54% vs. control - 0.08%, P = 0.04) with more FPG-controlled patients during pregnancy (94% vs. control 64.7%). Conclusion Clinical pharmacist assisted services in the management of pregnancy hyperglycemia fundamentally and significantly improve knowledge and disease control.

Citing Articles

Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes.

Orabone A, Do V, Cohen E Diabetes Metab Syndr Obes. 2022; 15:1911-1923.

PMID: 35757195 PMC: 9231415. DOI: 10.2147/DMSO.S342936.

The Role of Clinical Pharmacy in Preventing Prescribing Errors in the Emergency Department of a Governmental Hospital in Jordan: A Pre-Post Study.

H Abdel-Qader D, Saadi Ismael N, Al Meslamani A, Albassam A, El-Shara A, Lewis P Hosp Pharm. 2021; 56(6):681-689.

PMID: 34732922 PMC: 8559051. DOI: 10.1177/0018578720942231.

Impact of Clinical Pharmacist Interventions in Prescribing Errors in Hospitalized Diabetic Patients with Major Polypharmacy.

Abu-Naser D Hosp Pharm. 2021; 56(4):392-399.

PMID: 34381280 PMC: 8326857. DOI: 10.1177/0018578720985428.

Metformin Use in Gestational Diabetes: Awareness, Attitude, and Practice among Healthcare Professionals in Malaysia.

Daud N, Mohiuddin S, Ong Y, Yusof F, Yusoff F, Harun S J Pharm Bioallied Sci. 2021; 13(2):230-237.

PMID: 34349484 PMC: 8291112. DOI: 10.4103/jpbs.JPBS_542_20.

Physicians' perceptions, expectations, and experiences of clinical pharmacists in Jordan-2017.

Tahaineh L, Wazaify M, Alomoush F, Nasser S, Alrawashdh N, Abraham I Int J Clin Pharm. 2019; 41(5):1193-1201.

PMID: 31377967 DOI: 10.1007/s11096-019-00884-6.

References

Howorka K, Pumprla J, Gabriel M, Feiks A, Schlusche C, Nowotny C . Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out-patient education adapted for pregnancy. Diabet Med. 2002; 18(12):965-72. DOI: 10.1046/j.1464-5491.2001.00621.x. View

Elnour A, El Mugammar I, Jaber T, Revel T, McElnay J . Pharmaceutical care of patients with gestational diabetes mellitus. J Eval Clin Pract. 2008; 14(1):131-40. DOI: 10.1111/j.1365-2753.2007.00819.x. View

Inturrisi M, Lintner N, Sorem K . Diagnosis and treatment of hyperglycemia in pregnancy. Endocrinol Metab Clin North Am. 2011; 40(4):703-26. DOI: 10.1016/j.ecl.2011.09.002. View

Quinones M, Pio M, Chow D, Moss E, Hulstein J, Boatright S . Impact of clinical pharmacy services on outcomes and costs for indigent patients with diabetes. Am J Manag Care. 2016; 22(4):e147-52. View

Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352(24):2477-86. DOI: 10.1056/NEJMoa042973. View

Petrovic O, Belci D . A critical appraisal and potentially new conceptual approach to screening and diagnosis of gestational diabetes. J Obstet Gynaecol. 2017; 37(6):691-699. DOI: 10.1080/01443615.2017.1306692. View

Ebert T, Kralisch S, Wurst U, Lossner U, Kratzsch J, Bluher M . Betatrophin levels are increased in women with gestational diabetes mellitus compared to healthy pregnant controls. Eur J Endocrinol. 2015; 173(1):1-7. DOI: 10.1530/EJE-14-0815. View

Stein S, Stepan H, Kratzsch J, Verlohren M, Verlohren H, Drynda K . Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism. 2009; 59(1):33-7. DOI: 10.1016/j.metabol.2009.07.003. View

Guy G, Ling H, Garcia P, Poon L, Nicolaides K . Maternal cardiovascular function at 35-37 weeks' gestation: relation to maternal characteristics. Ultrasound Obstet Gynecol. 2016; 49(1):39-45. DOI: 10.1002/uog.17311. View

10.

Singh M, Pathak M, Paul A . A Study on Atherogenic Indices of Pregnancy Induced Hypertension Patients as Compared to Normal Pregnant Women. J Clin Diagn Res. 2015; 9(7):BC05-8. PMC: 4572947. DOI: 10.7860/JCDR/2015/13505.6241. View

11.

Hepler C, Strand L . Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47(3):533-43. View

12.

Zhang Y, Zhang H, Lu J, Zheng S, Long T, Li Y . Changes in serum adipocyte fatty acid-binding protein in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnancy. J Diabetes Investig. 2016; 7(5):797-804. PMC: 5009145. DOI: 10.1111/jdi.12484. View

13.

Assal J, Jacquemet S, Morel Y . The added value of therapy in diabetes: the education of patients for self-management of their disease. Metabolism. 1998; 46(12 Suppl 1):61-4. DOI: 10.1016/s0026-0495(97)90320-6. View

14.

Hopmans T, van Houten C, Kasius A, Kouznetsova O, Nguyen L, Rooijmans S . [Increased risk of type II diabetes mellitus and cardiovascular disease after gestational diabetes mellitus: a systematic review]. Ned Tijdschr Geneeskd. 2015; 159:A8043. View

15.

Dishi M, Hevner K, Qiu C, Fida N, Abetew D, Williams M . Early Pregnancy Maternal Hepatocyte Growth Factor and Risk of Gestational Diabetes. Br J Med Med Res. 2016; 9(1). PMC: 4856214. DOI: 10.9734/BJMMR/2015/18632. View

16.

Moon J, Kwak S, Jang H . Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus. Korean J Intern Med. 2017; 32(1):26-41. PMC: 5214732. DOI: 10.3904/kjim.2016.203. View

17.

Kim C, Newton K, Knopp R . Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002; 25(10):1862-8. DOI: 10.2337/diacare.25.10.1862. View

18.

Zhao P, Liu E, Qiao Y, Katzmarzyk P, Chaput J, Fogelholm M . Maternal gestational diabetes and childhood obesity at age 9-11: results of a multinational study. Diabetologia. 2016; 59(11):2339-2348. PMC: 5044880. DOI: 10.1007/s00125-016-4062-9. View

19.

Butt M, Mhd Ali A, Makmor Bakry M, Mustafa N . Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled study. Saudi Pharm J. 2016; 24(1):40-8. PMC: 4720029. DOI: 10.1016/j.jsps.2015.02.023. View

20.

Evans E, Patry R . Management of gestational diabetes mellitus and pharmacists' role in patient education. Am J Health Syst Pharm. 2004; 61(14):1460-5. DOI: 10.1093/ajhp/61.14.1460. View